vs

Side-by-side financial comparison of Accel Entertainment, Inc. (ACEL) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.

Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $341.4M, roughly 1.4× Accel Entertainment, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 4.7%, a 2.1% gap on every dollar of revenue. On growth, Accel Entertainment, Inc. posted the faster year-over-year revenue change (7.5% vs -1.7%). Over the past eight quarters, Accel Entertainment, Inc.'s revenue compounded faster (6.4% CAGR vs -0.1%).

Legendary Entertainment, LLC is an American mass media and film production company based in Burbank, California, founded by Thomas Tull in 2000. The company has often collaborated with the major studios, including Warner Bros. Pictures, Universal Pictures, Sony Pictures and Paramount Pictures, as well as streaming services such as Netflix and Hulu.

Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.

ACEL vs MD — Head-to-Head

Bigger by revenue
MD
MD
1.4× larger
MD
$493.8M
$341.4M
ACEL
Growing faster (revenue YoY)
ACEL
ACEL
+9.2% gap
ACEL
7.5%
-1.7%
MD
Higher net margin
MD
MD
2.1% more per $
MD
6.8%
4.7%
ACEL
Faster 2-yr revenue CAGR
ACEL
ACEL
Annualised
ACEL
6.4%
-0.1%
MD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ACEL
ACEL
MD
MD
Revenue
$341.4M
$493.8M
Net Profit
$16.2M
$33.7M
Gross Margin
Operating Margin
8.7%
9.9%
Net Margin
4.7%
6.8%
Revenue YoY
7.5%
-1.7%
Net Profit YoY
93.3%
10.5%
EPS (diluted)
$0.19
$0.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACEL
ACEL
MD
MD
Q4 25
$341.4M
$493.8M
Q3 25
$329.7M
$492.9M
Q2 25
$335.9M
$468.8M
Q1 25
$323.9M
$458.4M
Q4 24
$317.5M
$502.4M
Q3 24
$302.2M
$511.2M
Q2 24
$309.4M
$504.3M
Q1 24
$301.8M
$495.1M
Net Profit
ACEL
ACEL
MD
MD
Q4 25
$16.2M
$33.7M
Q3 25
$13.4M
$71.7M
Q2 25
$7.3M
$39.3M
Q1 25
$14.6M
$20.7M
Q4 24
$8.4M
$30.5M
Q3 24
$4.9M
$19.4M
Q2 24
$14.6M
$-153.0M
Q1 24
$7.4M
$4.0M
Operating Margin
ACEL
ACEL
MD
MD
Q4 25
8.7%
9.9%
Q3 25
7.7%
13.8%
Q2 25
8.0%
12.8%
Q1 25
8.0%
7.0%
Q4 24
6.5%
7.8%
Q3 24
7.2%
6.6%
Q2 24
7.3%
-31.3%
Q1 24
8.5%
3.2%
Net Margin
ACEL
ACEL
MD
MD
Q4 25
4.7%
6.8%
Q3 25
4.1%
14.5%
Q2 25
2.2%
8.4%
Q1 25
4.5%
4.5%
Q4 24
2.6%
6.1%
Q3 24
1.6%
3.8%
Q2 24
4.7%
-30.3%
Q1 24
2.5%
0.8%
EPS (diluted)
ACEL
ACEL
MD
MD
Q4 25
$0.19
$0.40
Q3 25
$0.16
$0.84
Q2 25
$0.08
$0.46
Q1 25
$0.17
$0.24
Q4 24
$0.09
$0.37
Q3 24
$0.06
$0.23
Q2 24
$0.17
$-1.84
Q1 24
$0.09
$0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACEL
ACEL
MD
MD
Cash + ST InvestmentsLiquidity on hand
$296.6M
$375.2M
Total DebtLower is stronger
$607.4M
$570.5M
Stockholders' EquityBook value
$269.7M
$865.9M
Total Assets
$1.1B
$2.2B
Debt / EquityLower = less leverage
2.25×
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACEL
ACEL
MD
MD
Q4 25
$296.6M
$375.2M
Q3 25
$290.2M
$340.1M
Q2 25
$264.6M
$224.7M
Q1 25
$271.9M
$99.0M
Q4 24
$281.3M
$229.9M
Q3 24
$265.1M
$103.8M
Q2 24
$254.9M
$19.4M
Q1 24
$253.9M
$8.0M
Total Debt
ACEL
ACEL
MD
MD
Q4 25
$607.4M
$570.5M
Q3 25
$595.4M
$577.2M
Q2 25
$595.5M
$583.9M
Q1 25
$580.7M
$590.5M
Q4 24
$595.4M
$597.1M
Q3 24
$554.1M
Q2 24
$565.7M
Q1 24
$539.9M
Stockholders' Equity
ACEL
ACEL
MD
MD
Q4 25
$269.7M
$865.9M
Q3 25
$267.1M
$890.7M
Q2 25
$260.5M
$833.8M
Q1 25
$259.1M
$789.2M
Q4 24
$255.0M
$764.9M
Q3 24
$206.7M
$732.5M
Q2 24
$209.1M
$706.5M
Q1 24
$202.1M
$856.2M
Total Assets
ACEL
ACEL
MD
MD
Q4 25
$1.1B
$2.2B
Q3 25
$1.1B
$2.2B
Q2 25
$1.1B
$2.1B
Q1 25
$1.0B
$2.0B
Q4 24
$1.0B
$2.2B
Q3 24
$950.2M
$2.1B
Q2 24
$950.3M
$2.0B
Q1 24
$919.1M
$2.2B
Debt / Equity
ACEL
ACEL
MD
MD
Q4 25
2.25×
0.66×
Q3 25
2.23×
0.65×
Q2 25
2.29×
0.70×
Q1 25
2.24×
0.75×
Q4 24
2.33×
0.78×
Q3 24
2.68×
Q2 24
2.71×
Q1 24
2.67×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACEL
ACEL
MD
MD
Operating Cash FlowLast quarter
$31.1M
$114.1M
Free Cash FlowOCF − Capex
$16.0M
FCF MarginFCF / Revenue
4.7%
Capex IntensityCapex / Revenue
4.4%
Cash ConversionOCF / Net Profit
1.92×
3.39×
TTM Free Cash FlowTrailing 4 quarters
$62.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACEL
ACEL
MD
MD
Q4 25
$31.1M
$114.1M
Q3 25
$55.2M
$137.3M
Q2 25
$19.8M
$137.2M
Q1 25
$44.8M
$-117.5M
Q4 24
$13.5M
$133.0M
Q3 24
$50.1M
$91.8M
Q2 24
$28.9M
$107.0M
Q1 24
$28.8M
$-125.2M
Free Cash Flow
ACEL
ACEL
MD
MD
Q4 25
$16.0M
Q3 25
$34.2M
Q2 25
$-6.2M
Q1 25
$18.0M
Q4 24
$2.1M
Q3 24
$33.1M
Q2 24
$11.4M
Q1 24
$8.1M
FCF Margin
ACEL
ACEL
MD
MD
Q4 25
4.7%
Q3 25
10.4%
Q2 25
-1.9%
Q1 25
5.6%
Q4 24
0.7%
Q3 24
11.0%
Q2 24
3.7%
Q1 24
2.7%
Capex Intensity
ACEL
ACEL
MD
MD
Q4 25
4.4%
Q3 25
6.4%
Q2 25
7.8%
Q1 25
8.3%
Q4 24
3.6%
Q3 24
5.6%
Q2 24
5.7%
Q1 24
6.8%
Cash Conversion
ACEL
ACEL
MD
MD
Q4 25
1.92×
3.39×
Q3 25
4.13×
1.91×
Q2 25
2.71×
3.49×
Q1 25
3.06×
-5.66×
Q4 24
1.62×
4.36×
Q3 24
10.23×
4.72×
Q2 24
1.98×
Q1 24
3.88×
-31.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACEL
ACEL

Video Gaming$319.1M93%
ATM Fees And Other Revenue$13.5M4%
Amusement$5.3M2%
Manufacturing$3.6M1%

MD
MD

Health Care Patient Service$421.6M85%
Hospitals Contracts$70.0M14%
Other$2.2M0%

Related Comparisons